$ANG-PA
American National Group Inc. Stock $ang-pa

$ang-pa Overview Financials Valuation SEC Filings Company Website

2021 Form 10-K Financial Statement

#000103982822000022 Filed on March 01, 2022

Income Statement

Concept	2021	2020 Q4	2020
Revenue	$3.689B	$1.030B	$2.425B
YoY Change	52.17%	-7.55%	-30.01%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$268.3M	$27.50M	$649.6M
YoY Change	-58.69%	-79.6%	640.51%
% of Gross Profit
Operating Expenses	$3.414B	$443.2M	$2.864B
YoY Change	19.19%	-34.35%	73.23%
Operating Profit
YoY Change
Interest Expense	$327.4M	-$576.6M	$1.256B
YoY Change	-73.93%	265.17%	-183.98%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$602.7M	$9.900M	$816.0M
YoY Change	-26.13%	-96.47%	158.57%
Income Tax	$128.8M	$1.200M	$144.5M
% Of Pretax Income	21.36%	12.12%	17.71%
Net Earnings	$474.0M	$8.700M	$671.5M
YoY Change	-29.41%	-96.05%	172.85%
Net Earnings / Revenue	12.85%	0.84%	27.69%
Basic Earnings Per Share	$4.58	-$0.07	$6.93
Diluted Earnings Per Share	$4.55	-$0.07	$6.90
COMMON SHARES
Basic Shares Outstanding	93.86M shares	92.02M shares	92.06M shares
Diluted Shares Outstanding	94.49M shares		92.39M shares

Balance Sheet

Concept	2021	2020 Q4	2020
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$4.509B	$9.096B	$9.096B
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$59.10B	$52.29B	$52.29B
YoY Change	13.01%	-5.81%	-5.81%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$78.35B	$71.69B	$71.69B
YoY Change	9.29%	2.86%	2.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt	$574.7M	$574.0M	$574.0M
YoY Change	0.12%	-11.96%	-11.96%
Other Long-Term Liabilities	$2.080B	$1.668B	$1.668B
YoY Change	24.7%	-22.27%	-22.27%
Total Long-Term Liabilities	$2.655B	$2.242B	$2.242B
YoY Change	18.41%	-19.87%	-19.87%
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities	$2.655B	$2.242B	$2.242B
Total Liabilities	$72.03B	$65.34B	$65.34B
YoY Change	10.23%	0.33%	0.33%
SHAREHOLDERS EQUITY
Retained Earnings		$2.369B
YoY Change		33.91%
Common Stock		$95.72M
YoY Change		5.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares		6.517M shares
Shareholders Equity	$6.323B	$6.349B	$6.349B
YoY Change
Total Liabilities & Shareholders Equity	$78.35B	$71.69B	$71.69B
YoY Change	9.29%	2.86%	2.86%

Cashflow Statement

Concept	2021	2020 Q4	2020
OPERATING ACTIVITIES
Net Income	$474.0M	$8.700M	$671.5M
YoY Change	-29.41%	-96.05%	172.85%
Depreciation, Depletion And Amortization	$268.3M	$27.50M	$649.6M
YoY Change	-58.69%	-79.6%	640.51%
Cash From Operating Activities	$4.233B	$949.8M	$1.305B
YoY Change	224.38%	-10.66%	-61.06%
INVESTING ACTIVITIES
Capital Expenditures	$18.11M	-$800.0K	$13.24M
YoY Change	36.77%	-11.11%	229.19%
Acquisitions
YoY Change
Other Investing Activities	-$6.206B	$4.507B	$5.148B
YoY Change	-220.56%	-3132.71%	-268.73%
Cash From Investing Activities	-$6.224B	$4.506B	$5.135B
YoY Change	-221.22%	-3113.98%	-268.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$94.56M		-$173.0M
YoY Change	-154.67%		10128.68%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$2.595B	983.2M	$362.5M
YoY Change	-815.89%	307.97%	-78.06%
NET CHANGE
Cash From Operating Activities	$4.233B	949.8M	$1.305B
Cash From Investing Activities	-$6.224B	4.506B	$5.135B
Cash From Financing Activities	-$2.595B	983.2M	$362.5M
Net Change In Cash	-$4.587B	6.439B	$6.802B
YoY Change	-167.43%	457.67%	249.01%
FREE CASH FLOW
Cash From Operating Activities	$4.233B	$949.8M	$1.305B
Capital Expenditures	$18.11M	-$800.0K	$13.24M
Free Cash Flow	$4.215B	$950.6M	$1.292B
YoY Change	226.31%	-10.66%	-61.41%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	1000000000	USD
CY2020Q4	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	1888000	USD
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001039828
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2019	us-gaap	Other Than Temporary Impairment Loss Debt Securities Portion Recognized In Earnings OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings	18726000	USD
CY2021	ael	Mean Reversion Period MeanReversionPeriod	P8Y
CY2021	ael	Mean Reversion Period MeanReversionPeriod	P8Y
CY2020	ael	Mean Reversion Period MeanReversionPeriod	P8Y
CY2020	ael	Mean Reversion Period MeanReversionPeriod	P8Y
CY2020	ael	Mean Reversion Period MeanReversionPeriod	P8Y
CY2020	ael	Mean Reversion Period MeanReversionPeriod	P8Y
CY2021Q4	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	2264000	USD
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-31911
CY2021	dei	Entity Registrant Name EntityRegistrantName	American Equity Investment Life Holding Co
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	IA
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	42-1447959
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	6000 Westown Parkway
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	West Des Moines
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	IA
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	50266
CY2021	dei	City Area Code CityAreaCode	515
CY2021	dei	Local Phone Number LocalPhoneNumber	221-0002
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	445097000	USD
CY2020Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	398082000	USD
CY2021Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	2222769000	USD
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	2945865287	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	96949174	shares
CY2021	dei	Auditor Name AuditorName	Ernst & Young LLP
CY2021	dei	Auditor Location AuditorLocation	Des Moines, Iowa
CY2021	dei	Auditor Firm AuditorFirmId	42
CY2020	dei	Auditor Name AuditorName	KPMG LLP
CY2020	dei	Auditor Location AuditorLocation	Des Moines, Iowa
CY2020	dei	Auditor Firm AuditorFirmId	185
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	46999183000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	42304736000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	2846000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	64771000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	51305943000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	47538893000	USD
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	24024000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	31029000	USD
CY2021Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	5687998000	USD
CY2020Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	4165489000	USD
CY2021Q4	us-gaap	Derivative Assets DerivativeAssets	1277480000	USD
CY2020Q4	us-gaap	Derivative Assets DerivativeAssets	1310954000	USD
CY2021Q4	us-gaap	Other Investments OtherInvestments	1767144000	USD
CY2020Q4	us-gaap	Other Investments OtherInvestments	590078000	USD
CY2021Q4	us-gaap	Investments Investments	60376504000	USD
CY2020Q4	us-gaap	Investments Investments	53605414000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4508982000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9095522000	USD
CY2021Q4	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	2264000	USD
CY2020Q4	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	1888000	USD
CY2021Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	8850608000	USD
CY2020Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	4844927000	USD
CY2020Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	862000	USD
CY2020Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	2225199000	USD
CY2021Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	1546073000	USD
CY2020Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	1448375000	USD
CY2021Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	166586000	USD
CY2021Q4	us-gaap	Other Assets OtherAssets	232490000	USD
CY2020Q4	us-gaap	Other Assets OtherAssets	70198000	USD
CY2021Q4	us-gaap	Assets Assets	78349109000	USD
CY2020Q4	us-gaap	Assets Assets	71688579000	USD
CY2021Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	65477778000	USD
CY2020Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	62352882000	USD
CY2021Q4	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	226844000	USD
CY2020Q4	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	240904000	USD
CY2021Q4	us-gaap	Notes Payable NotesPayable	496250000	USD
CY2020Q4	us-gaap	Notes Payable NotesPayable	495668000	USD
CY2021Q4	us-gaap	Subordinated Debt SubordinatedDebt	78421000	USD
CY2020Q4	us-gaap	Subordinated Debt SubordinatedDebt	78112000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	541972000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	504000000	USD
CY2021Q4	us-gaap	Funds Held Under Reinsurance Agreements Liability FundsHeldUnderReinsuranceAgreementsLiability	3124740000	USD
CY2020Q4	us-gaap	Funds Held Under Reinsurance Agreements Liability FundsHeldUnderReinsuranceAgreementsLiability	0	USD
CY2021Q4	us-gaap	Other Liabilities OtherLiabilities	2079977000	USD
CY2020Q4	us-gaap	Other Liabilities OtherLiabilities	1668025000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	72025982000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	65339591000	USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	92513517	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	92513517	shares
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1681127000	USD
CY2021Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	9936715	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	95720622	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	95720622	shares
CY2020Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	6516525	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	92514000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	95721000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1614374000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1848789000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2203557000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2767422000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2368555000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	6323127000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	6348988000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	78349109000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	71688579000	USD
CY2019	us-gaap	Premiums Earned Net PremiumsEarnedNet	23534000	USD
CY2021	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	242631000	USD
CY2021	us-gaap	Premiums Earned Net PremiumsEarnedNet	58202000	USD
CY2020	us-gaap	Premiums Earned Net PremiumsEarnedNet	39382000	USD
CY2020	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	251227000	USD
CY2019	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	240035000	USD
CY2021	us-gaap	Net Investment Income NetInvestmentIncome	2037475000	USD
CY2020	us-gaap	Net Investment Income NetInvestmentIncome	2182078000	USD
CY2019	us-gaap	Net Investment Income NetInvestmentIncome	2307635000	USD
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1348735000	USD
CY2020	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	34666000	USD
CY2019	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	906906000	USD
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	-13242000	USD
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	-80680000	USD
CY2019	us-gaap	Gain Loss On Investments GainLossOnInvestments	6962000	USD
CY2021	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2021	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	0	USD
CY2020	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2019	us-gaap	Impairment Of Investments ImpairmentOfInvestments	18511000	USD
CY2020	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	0	USD
CY2019	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-215000	USD
CY2021	us-gaap	Other Than Temporary Impairment Loss Debt Securities Portion Recognized In Earnings OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings	0	USD
CY2020	us-gaap	Other Than Temporary Impairment Loss Debt Securities Portion Recognized In Earnings OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings	0	USD
CY2019	us-gaap	Other Than Temporary Impairment Loss Debt Securities Portion Recognized In Earnings OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings	18726000	USD
CY2021	us-gaap	Other Income OtherIncome	15670000	USD
CY2020	us-gaap	Other Income OtherIncome	0	USD
CY2019	us-gaap	Other Income OtherIncome	0	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2024000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2001000	USD
CY2021	us-gaap	Revenues Revenues	3689471000	USD
CY2020	us-gaap	Revenues Revenues	2424649000	USD
CY2019	us-gaap	Revenues Revenues	3464345000	USD
CY2021	us-gaap	Policyholder Benefits And Claims Incurred Other PolicyholderBenefitsAndClaimsIncurredOther	67983000	USD
CY2020	us-gaap	Policyholder Benefits And Claims Incurred Other PolicyholderBenefitsAndClaimsIncurredOther	49742000	USD
CY2019	us-gaap	Policyholder Benefits And Claims Incurred Other PolicyholderBenefitsAndClaimsIncurredOther	35418000	USD
CY2021	us-gaap	Policyholder Benefits And Claims Incurred Life And Annuity PolicyholderBenefitsAndClaimsIncurredLifeAndAnnuity	2681406000	USD
CY2020	us-gaap	Policyholder Benefits And Claims Incurred Life And Annuity PolicyholderBenefitsAndClaimsIncurredLifeAndAnnuity	1543270000	USD
CY2019	us-gaap	Policyholder Benefits And Claims Incurred Life And Annuity PolicyholderBenefitsAndClaimsIncurredLifeAndAnnuity	1287576000	USD
CY2021	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	152692000	USD
CY2020	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	438164000	USD
CY2019	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	88585000	USD
CY2021	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	358302000	USD
CY2020	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	1286787000	USD
CY2019	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	-1454042000	USD
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	25581000	USD
CY2020	us-gaap	Interest Expense Debt InterestExpenseDebt	25552000	USD
CY2019	us-gaap	Interest Expense Debt InterestExpenseDebt	25525000	USD
CY2021	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	5324000	USD
CY2020	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	5557000	USD
CY2019	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	15764000	USD
CY2021	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	268328000	USD
CY2020	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	649554000	USD
CY2019	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	87717000	USD
CY2021	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	243712000	USD
CY2020	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	183636000	USD
CY2019	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	154153000	USD
CY2021	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	3086724000	USD
CY2020	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	1608688000	USD
CY2019	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	3148780000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	602747000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	815961000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	315565000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	128755000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	144501000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	69475000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	473992000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	671460000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	246090000	USD
CY2021	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	43675000	USD
CY2020	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	33515000	USD
CY2019	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	430317000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	637945000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	246090000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.58
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	6.93
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.70
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.55
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.90
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.68
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	93860000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	92055000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	91139000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	94491000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	92392000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	91782000	shares
CY2021	us-gaap	Net Income Loss NetIncomeLoss	473992000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	671460000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	246090000	USD
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-441008000	USD
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1058289000	USD
CY2019	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1765107000	USD
CY2021	us-gaap	Other Than Temporary Impairment Losses Investments Reclassification Adjustment Of Noncredit Portion Included In Net Income Availabeforsale Securities Before Tax OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedInNetIncomeAvailabeforsaleSecuritiesBeforeTax	0	USD
CY2020	us-gaap	Other Than Temporary Impairment Losses Investments Reclassification Adjustment Of Noncredit Portion Included In Net Income Availabeforsale Securities Before Tax OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedInNetIncomeAvailabeforsaleSecuritiesBeforeTax	0	USD
CY2019	us-gaap	Other Than Temporary Impairment Losses Investments Reclassification Adjustment Of Noncredit Portion Included In Net Income Availabeforsale Securities Before Tax OtherThanTemporaryImpairmentLossesInvestmentsReclassificationAdjustmentOfNoncreditPortionIncludedInNetIncomeAvailabeforsaleSecuritiesBeforeTax	103000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	4044000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-16690000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-8323000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-445052000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	1074979000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	1773533000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-90284000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	225746000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	372472000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-354768000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	849233000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1401061000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	119224000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1520693000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1647151000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	2404796000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	246090000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1401061000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11295000	USD
CY2019	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.30
CY2019	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	27304000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	4426522000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	671460000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	849233000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10215000	USD
CY2020	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	165094000	USD
CY2020	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	33515000	USD
CY2020	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.32
CY2020	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	28859000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	6348988000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	473992000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-354768000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	128423000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	24601000	USD
CY2021	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	99415000	USD
CY2021	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	43675000	USD
CY2021	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.34
CY2021	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	31450000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	6323127000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	473992000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	671460000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	246090000	USD
CY2021	ael	Interest Sensitive And Index Product Benefits InterestSensitiveAndIndexProductBenefits	2681406000	USD
CY2020	ael	Interest Sensitive And Index Product Benefits InterestSensitiveAndIndexProductBenefits	1543270000	USD
CY2019	ael	Interest Sensitive And Index Product Benefits InterestSensitiveAndIndexProductBenefits	1287576000	USD
CY2021	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	152692000	USD
CY2020	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	438164000	USD
CY2019	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	88585000	USD
CY2021	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	242631000	USD
CY2020	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	251227000	USD
CY2019	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	240035000	USD
CY2021	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	358302000	USD
CY2020	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	1286787000	USD
CY2019	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	-1454042000	USD
CY2021	us-gaap	Increase Decrease In Other Insurance Liabilities IncreaseDecreaseInOtherInsuranceLiabilities	40090000	USD
CY2020	us-gaap	Increase Decrease In Other Insurance Liabilities IncreaseDecreaseInOtherInsuranceLiabilities	8694000	USD
CY2019	us-gaap	Increase Decrease In Other Insurance Liabilities IncreaseDecreaseInOtherInsuranceLiabilities	-3546000	USD
CY2021	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	307857000	USD
CY2020	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	255154000	USD
CY2019	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	422516000	USD
CY2021	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	268328000	USD
CY2020	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	649554000	USD
CY2019	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	87717000	USD
CY2021	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	5527000	USD
CY2020	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	5199000	USD
CY2019	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	4068000	USD
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-19861000	USD
CY2020	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-57437000	USD
CY2019	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-25846000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2024000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2001000	USD
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	-13242000	USD
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	-80680000	USD
CY2019	ael	Gain Losson Investments Including Other Than Temporary Impairment Losses GainLossonInvestmentsIncludingOtherThanTemporaryImpairmentLosses	-11764000	USD
CY2021	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	1348704000	USD
CY2020	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	34668000	USD
CY2019	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	906201000	USD
CY2021	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	12409000	USD
CY2020	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	1968000	USD
CY2019	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	2753000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	10215000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	11295000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	141071000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	56947000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	24601000	USD
CY2021	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	47015000	USD
CY2020	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	-74744000	USD
CY2019	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	4097000	USD
CY2021	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	-165724000	USD
CY2020	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	-1291000	USD
CY2019	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	26966000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	4464000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	849000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	5607000	USD
CY2021	us-gaap	Increase Decrease In Other Policyholder Funds IncreaseDecreaseInOtherPolicyholderFunds	-19809000	USD
CY2020	us-gaap	Increase Decrease In Other Policyholder Funds IncreaseDecreaseInOtherPolicyholderFunds	-21865000	USD
CY2019	us-gaap	Increase Decrease In Other Policyholder Funds IncreaseDecreaseInOtherPolicyholderFunds	-21971000	USD
CY2021	us-gaap	Increase Decrease Cash Collateral From Counterparties IncreaseDecreaseCashCollateralFromCounterparties	17423000	USD
CY2020	us-gaap	Increase Decrease Cash Collateral From Counterparties IncreaseDecreaseCashCollateralFromCounterparties	-72413000	USD
CY2019	us-gaap	Increase Decrease Cash Collateral From Counterparties IncreaseDecreaseCashCollateralFromCounterparties	1190656000	USD
CY2021	us-gaap	Increase Decrease In Cash Collateral For Loaned Securities IncreaseDecreaseInCashCollateralForLoanedSecurities	0	USD
CY2020	us-gaap	Increase Decrease In Cash Collateral For Loaned Securities IncreaseDecreaseInCashCollateralForLoanedSecurities	-495039000	USD
CY2019	us-gaap	Increase Decrease In Cash Collateral For Loaned Securities IncreaseDecreaseInCashCollateralForLoanedSecurities	495101000	USD
CY2021	us-gaap	Increase Decrease In Reinsurance Payables IncreaseDecreaseInReinsurancePayables	3124740000	USD
CY2020	us-gaap	Increase Decrease In Reinsurance Payables IncreaseDecreaseInReinsurancePayables	0	USD
CY2019	us-gaap	Increase Decrease In Reinsurance Payables IncreaseDecreaseInReinsurancePayables	0	USD
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-221726000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	38995000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-28607000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	13338000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-804000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	7425000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4233164000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1304986000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3351402000	USD
CY2021	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	4490736000	USD
CY2020	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	8291316000	USD
CY2019	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	3266821000	USD
CY2021	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	862666000	USD
CY2020	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	378812000	USD
CY2019	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	294356000	USD
CY2021	us-gaap	Proceeds From Derivative Instrument Investing Activities ProceedsFromDerivativeInstrumentInvestingActivities	2260959000	USD
CY2020	us-gaap	Proceeds From Derivative Instrument Investing Activities ProceedsFromDerivativeInstrumentInvestingActivities	860520000	USD
CY2019	us-gaap	Proceeds From Derivative Instrument Investing Activities ProceedsFromDerivativeInstrumentInvestingActivities	657885000	USD
CY2021	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	368837000	USD
CY2020	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	4324000	USD
CY2019	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	472549000	USD
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	9206733000	USD
CY2020	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	2429114000	USD
CY2019	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	5509314000	USD
CY2021	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	2386712000	USD
CY2020	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	1121756000	USD
CY2019	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	799037000	USD
CY2021	us-gaap	Payments To Acquire Real Estate Held For Investment PaymentsToAcquireRealEstateHeldForInvestment	335767000	USD
CY2020	us-gaap	Payments To Acquire Real Estate Held For Investment PaymentsToAcquireRealEstateHeldForInvestment	0	USD
CY2019	us-gaap	Payments To Acquire Real Estate Held For Investment PaymentsToAcquireRealEstateHeldForInvestment	0	USD
CY2021	us-gaap	Payments For Derivative Instrument Investing Activities PaymentsForDerivativeInstrumentInvestingActivities	748061000	USD
CY2020	us-gaap	Payments For Derivative Instrument Investing Activities PaymentsForDerivativeInstrumentInvestingActivities	730333000	USD
CY2019	us-gaap	Payments For Derivative Instrument Investing Activities PaymentsForDerivativeInstrumentInvestingActivities	823077000	USD
CY2021	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	1512123000	USD
CY2020	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	105925000	USD
CY2019	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	611047000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	18109000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13240000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4022000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6224307000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	5134604000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3054886000	USD
CY2021	us-gaap	Proceeds From Annuities And Investment Certificates ProceedsFromAnnuitiesAndInvestmentCertificates	5910024000	USD
CY2020	us-gaap	Proceeds From Annuities And Investment Certificates ProceedsFromAnnuitiesAndInvestmentCertificates	3648936000	USD
CY2019	us-gaap	Proceeds From Annuities And Investment Certificates ProceedsFromAnnuitiesAndInvestmentCertificates	4951211000	USD
CY2021	us-gaap	Increase Decrease In Reinsurance Recoverable IncreaseDecreaseInReinsuranceRecoverable	3187332000	USD
CY2020	us-gaap	Increase Decrease In Reinsurance Recoverable IncreaseDecreaseInReinsuranceRecoverable	-430644000	USD
CY2019	us-gaap	Increase Decrease In Reinsurance Recoverable IncreaseDecreaseInReinsuranceRecoverable	-91238000	USD
CY2021	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	5145193000	USD
CY2020	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	4040054000	USD
CY2019	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	3584960000	USD
CY2021	us-gaap	Repayments Of Subordinated Debt RepaymentsOfSubordinatedDebt	0	USD
CY2020	us-gaap	Repayments Of Subordinated Debt RepaymentsOfSubordinatedDebt	81450000	USD
CY2019	us-gaap	Repayments Of Subordinated Debt RepaymentsOfSubordinatedDebt	88160000	USD
CY2021	us-gaap	Proceeds From Payments For In Securities Sold Under Agreements To Repurchase ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase	0	USD
CY2020	us-gaap	Proceeds From Payments For In Securities Sold Under Agreements To Repurchase ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase	0	USD
CY2019	us-gaap	Proceeds From Payments For In Securities Sold Under Agreements To Repurchase ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase	-109298000	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4854000	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	338061000	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1691000	USD
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	99415000	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	165094000	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2021	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	290260000	USD
CY2019	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	388893000	USD
CY2021	us-gaap	Increase Decrease In Outstanding Checks Financing Activities IncreaseDecreaseInOutstandingChecksFinancingActivities	-3210000	USD
CY2020	us-gaap	Increase Decrease In Outstanding Checks Financing Activities IncreaseDecreaseInOutstandingChecksFinancingActivities	3611000	USD
CY2019	us-gaap	Increase Decrease In Outstanding Checks Financing Activities IncreaseDecreaseInOutstandingChecksFinancingActivities	29169000	USD
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	31450000	USD
CY2020	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	28859000	USD
CY2019	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	27304000	USD
CY2021	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	43675000	USD
CY2020	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	33515000	USD
CY2019	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2595397000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	362540000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1652480000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-4586540000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	6802130000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1948996000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9095522000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2293392000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	344396000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4508982000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9095522000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2293392000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	30000000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	31427000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	42879000	USD
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	165537000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4842000	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	28413000	USD
CY2021	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	95160000	USD
CY2020	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	93610000	USD
CY2019	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	177941000	USD
CY2021Q4	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	50	states
CY2021	ael	Fixed Index Annuities FixedIndexAnnuities	3026211000	USD
CY2020	ael	Fixed Index Annuities FixedIndexAnnuities	2309580000	USD
CY2019	ael	Fixed Index Annuities FixedIndexAnnuities	4603490000	USD
CY2021	ael	Fixed Rate Annuities Annual Reset FixedRateAnnuitiesAnnualReset	6000000	USD
CY2020	ael	Fixed Rate Annuities Annual Reset FixedRateAnnuitiesAnnualReset	7846000	USD
CY2019	ael	Fixed Rate Annuities Annual Reset FixedRateAnnuitiesAnnualReset	10665000	USD
CY2021	ael	Fixed Rate Annuities Multi Year FixedRateAnnuitiesMultiYear	2452994000	USD
CY2020	ael	Fixed Rate Annuities Multi Year FixedRateAnnuitiesMultiYear	1295843000	USD
CY2019	ael	Fixed Rate Annuities Multi Year FixedRateAnnuitiesMultiYear	47016000	USD
CY2021	ael	Single Premium Immediate Annuities Spias SinglePremiumImmediateAnnuitiesSpias	59816000	USD
CY2020	ael	Single Premium Immediate Annuities Spias SinglePremiumImmediateAnnuitiesSpias	33461000	USD
CY2019	ael	Single Premium Immediate Annuities Spias SinglePremiumImmediateAnnuitiesSpias	12002000	USD
CY2021	ael	Premiums And Annuity Deposits PremiumsAndAnnuityDeposits	5545021000	USD
CY2020	ael	Premiums And Annuity Deposits PremiumsAndAnnuityDeposits	3646730000	USD
CY2019	ael	Premiums And Annuity Deposits PremiumsAndAnnuityDeposits	4673173000	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Estimates and Assumptions</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles ("GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions are utilized in the calculation of deferred policy acquisition costs, deferred sales inducements, policy benefit reserves, including the liability for lifetime income benefit riders and the fair value of embedded derivatives in fixed index annuity contracts, valuation of derivatives, valuation of investments, allowances for credit losses on available-for-sale fixed maturity securities, allowances for loan losses on mortgage loans and valuation allowances on deferred tax assets. A description of each critical </span></div>estimate is incorporated within the discussion of the related accounting policies which follow. It is reasonably possible that actual experience could differ from the estimates and assumptions utilized.
CY2021	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain amounts in the prior years' consolidated financial statements and related footnotes thereto have been reclassified to conform with the current year presentation.</span></div>
CY2020Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	2225199000	USD
CY2020Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	1448375000	USD
CY2020Q4	us-gaap	Assets Assets	71688579000	USD
CY2020Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	62352882000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	504000000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	65339591000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2203557000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	6348988000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	71688579000	USD
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1058289000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	1074979000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	225746000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	849233000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1520693000	USD
CY2019	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1765107000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	1773533000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	372472000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1401061000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1647151000	USD
CY2021Q4	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	520100000	USD
CY2020Q4	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	179700000	USD
CY2021Q4	ael	Other Investments Short Term Loans Fair Value Disclosure OtherInvestmentsShortTermLoansFairValueDisclosure	320000000	USD
CY2020Q4	ael	Other Investments Short Term Loans Fair Value Disclosure OtherInvestmentsShortTermLoansFairValueDisclosure	0	USD
CY2021Q4	us-gaap	Cash Surrender Value Fair Value Disclosure CashSurrenderValueFairValueDisclosure	384300000	USD
CY2020Q4	us-gaap	Cash Surrender Value Fair Value Disclosure CashSurrenderValueFairValueDisclosure	373600000	USD
CY2020Q4	ael	Expected Costof Annual Call Options ExpectedCostofAnnualCallOptions	0.0210
CY2021Q4	ael	Expected Costof Annual Call Options ExpectedCostofAnnualCallOptions	0.0210
CY2020Q4	ael	Expected Costof Annual Call Options ExpectedCostofAnnualCallOptions	0.0210
CY2019Q4	ael	Expected Costof Annual Call Options ExpectedCostofAnnualCallOptions	0.0290
CY2019	ael	Experience Study Productswith Lifetime Income Benefit Riders Period ExperienceStudyProductswithLifetimeIncomeBenefitRidersPeriod	P10Y
CY2018Q4	ael	Expected Costof Annual Call Options ExpectedCostofAnnualCallOptions	0.0310
CY2019Q4	ael	Expected Costof Annual Call Options ExpectedCostofAnnualCallOptions	0.0290
CY2019	ael	Mean Reversion Period MeanReversionPeriod	P20Y
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss	46999183000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	4421976000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	112370000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	2846000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	51305943000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss	42304736000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	5549754000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	250826000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	64771000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	47538893000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	400700000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	377500000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	1950504000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	1968323000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	7573038000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	7962521000	USD
CY2021Q4	ael	Debt Securities Availableforsale Maturity Allocatedand Single Maturity Dateafter Ten Years Through Twenty Years Fair Value DebtSecuritiesAvailableforsaleMaturityAllocatedandSingleMaturityDateafterTenYearsThroughTwentyYearsFairValue	12053093000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	7230026000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	7860389000	USD
CY2021Q4	ael	Debt Securities Availableforsale Maturity Allocatedand Single Maturity Dateafter Ten Yearsthrough Twenty Years Amortized Cost DebtSecuritiesAvailableforsaleMaturityAllocatedandSingleMaturityDateafterTenYearsthroughTwentyYearsAmortizedCost	10119850000	USD
CY2021Q4	ael	Debt Securities Availableforsale Maturity Allocatedand Single Maturity Dateafter Twenty Years Amortized Cost DebtSecuritiesAvailableforsaleMaturityAllocatedandSingleMaturityDateafterTwentyYearsAmortizedCost	9133449000	USD
CY2021Q4	ael	Debt Securities Availableforsale Maturity Allocatedand Single Maturity Dateafter Twenty Years Fair Value DebtSecuritiesAvailableforsaleMaturityAllocatedandSingleMaturityDateafterTwentyYearsFairValue	10224400000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	36006867000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	40068726000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	46999183000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	51305943000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	4309606000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	5297040000	USD
CY2021Q4	ael	Other Comprehensive Income Loss Adjustments For Assumed Changes In Amortization Of Deferred Policy Acquisition Costs Deferred Sales Inducements And Policy Benefit Reserves OtherComprehensiveIncomeLossAdjustmentsForAssumedChangesInAmortizationOfDeferredPolicyAcquisitionCostsDeferredSalesInducementsAndPolicyBenefitReserves	1993869000	USD
CY2020Q4	ael	Other Comprehensive Income Loss Adjustments For Assumed Changes In Amortization Of Deferred Policy Acquisition Costs Deferred Sales Inducements And Policy Benefit Reserves OtherComprehensiveIncomeLossAdjustmentsForAssumedChangesInAmortizationOfDeferredPolicyAcquisitionCostsDeferredSalesInducementsAndPolicyBenefitReserves	2536251000	USD
CY2021Q4	ael	Other Comprehensive Income Valuation Allowance Deferred Tax Asset Reversal OtherComprehensiveIncomeValuationAllowanceDeferredTaxAssetReversal	22534000	USD
CY2020Q4	ael	Other Comprehensive Income Valuation Allowance Deferred Tax Asset Reversal OtherComprehensiveIncomeValuationAllowanceDeferredTaxAssetReversal	22534000	USD
CY2021Q4	ael	Accumulated Other Comprehensive Income Loss Availableforsale Securities Deferred Income Tax Expense Benefit AccumulatedOtherComprehensiveIncomeLossAvailableforsaleSecuritiesDeferredIncomeTaxExpenseBenefit	489482000	USD
CY2020Q4	ael	Accumulated Other Comprehensive Income Loss Availableforsale Securities Deferred Income Tax Expense Benefit AccumulatedOtherComprehensiveIncomeLossAvailableforsaleSecuritiesDeferredIncomeTaxExpenseBenefit	579766000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1848789000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2203557000	USD
CY2021Q4	ael	Debt Securities Available For Sale Percent Investment Grade DebtSecuritiesAvailableForSalePercentInvestmentGrade	0.98
CY2020Q4	ael	Debt Securities Available For Sale Percent Investment Grade DebtSecuritiesAvailableForSalePercentInvestmentGrade	0.97
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	46999183000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	51305943000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	42304736000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	47538893000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	1427	Securities
CY2020Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	843	Securities
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	5735135000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	51758000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	2072853000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	63458000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	7807988000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	115216000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	2992944000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	122908000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	2771976000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	192689000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	5764920000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	315597000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	2800000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	64800000	USD
CY2021Q4	ael	Debt Securities Available For Sale Unrealized Loss Position Percent Investment Grade DebtSecuritiesAvailableForSaleUnrealizedLossPositionPercentInvestmentGrade	0.85
CY2020Q4	ael	Debt Securities Available For Sale Unrealized Loss Position Percent Investment Grade DebtSecuritiesAvailableForSaleUnrealizedLossPositionPercentInvestmentGrade	0.75
CY2021	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	-987434000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	1955496000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	3549007000	USD
CY2021	ael	Adjustments For Assumed Changes In Amortization Of Deferred Policy Acquisition Costs Deferred Sales Inducements And Policy Benefit Reserves AdjustmentsForAssumedChangesInAmortizationOfDeferredPolicyAcquisitionCostsDeferredSalesInducementsAndPolicyBenefitReserves	542382000	USD
CY2020	ael	Adjustments For Assumed Changes In Amortization Of Deferred Policy Acquisition Costs Deferred Sales Inducements And Policy Benefit Reserves AdjustmentsForAssumedChangesInAmortizationOfDeferredPolicyAcquisitionCostsDeferredSalesInducementsAndPolicyBenefitReserves	-880517000	USD
CY2019	ael	Adjustments For Assumed Changes In Amortization Of Deferred Policy Acquisition Costs Deferred Sales Inducements And Policy Benefit Reserves AdjustmentsForAssumedChangesInAmortizationOfDeferredPolicyAcquisitionCostsDeferredSalesInducementsAndPolicyBenefitReserves	-1775474000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	-90284000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	225746000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	372472000	USD
CY2021	ael	Changes In Net Unrealized Gains Losses Adjustments For Effect On Other Balance Sheet Accounts ChangesInNetUnrealizedGainsLossesAdjustmentsForEffectOnOtherBalanceSheetAccounts	632666000	USD
CY2020	ael	Changes In Net Unrealized Gains Losses Adjustments For Effect On Other Balance Sheet Accounts ChangesInNetUnrealizedGainsLossesAdjustmentsForEffectOnOtherBalanceSheetAccounts	-1106263000	USD
CY2019	ael	Changes In Net Unrealized Gains Losses Adjustments For Effect On Other Balance Sheet Accounts ChangesInNetUnrealizedGainsLossesAdjustmentsForEffectOnOtherBalanceSheetAccounts	-2147946000	USD
CY2020	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	5400000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-354768000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	849233000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1401061000	USD
CY2021	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	2101892000	USD
CY2020	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	2214550000	USD
CY2019	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	2329478000	USD
CY2021	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	64417000	USD
CY2020	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	32472000	USD
CY2019	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	21843000	USD
CY2021	us-gaap	Net Investment Income NetInvestmentIncome	2037475000	USD
CY2020	us-gaap	Net Investment Income NetInvestmentIncome	2182078000	USD
CY2019	us-gaap	Net Investment Income NetInvestmentIncome	2307635000	USD
CY2021	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	800000000	USD
CY2021	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	3700000000	USD
CY2020	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	2900000000	USD
CY2019	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	2300000000	USD
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	-13242000	USD
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	-80680000	USD
CY2019	us-gaap	Gain Loss On Investments GainLossOnInvestments	6962000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	64771000	USD
CY2021	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded	1112000	USD
CY2021	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal	-482000	USD
CY2021	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Sell Before Recovery DebtSecuritiesAvailableForSaleAllowanceForCreditLossSellBeforeRecovery	209000	USD
CY2021	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Securities Sold DebtSecuritiesAvailableForSaleAllowanceForCreditLossSecuritiesSold	50758000	USD
CY2021	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff	10032000	USD
CY2021	ael	Debt Securities Available For Sale Allowance For Credit Loss Recoveries Of Amounts Previously Written Off DebtSecuritiesAvailableForSaleAllowanceForCreditLossRecoveriesOfAmountsPreviouslyWrittenOff	1556000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	2846000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	0	USD
CY2020	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded	94560000	USD
CY2020	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Sell Before Recovery DebtSecuritiesAvailableForSaleAllowanceForCreditLossSellBeforeRecovery	22436000	USD
CY2020	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Securities Sold DebtSecuritiesAvailableForSaleAllowanceForCreditLossSecuritiesSold	7353000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	64771000	USD
CY2021Q4	us-gaap	Assets Held By Insurance Regulators AssetsHeldByInsuranceRegulators	49300000000	USD
CY2020Q4	us-gaap	Assets Held By Insurance Regulators AssetsHeldByInsuranceRegulators	53500000000	USD
CY2021Q4	us-gaap	Fair Value Concentration Of Risk Investments FairValueConcentrationOfRiskInvestments	0	USD
CY2020Q4	us-gaap	Fair Value Concentration Of Risk Investments FairValueConcentrationOfRiskInvestments	0	USD
CY2021Q4	ael	Financing Receivable Numberof Portfolio Segments FinancingReceivableNumberofPortfolioSegments	3	portfolio_segment
CY2021Q4	us-gaap	Financing Receivable Loan In Process FinancingReceivableLoanInProcess	370400000	USD
CY2021Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	5687998000	USD
CY2020Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	4165489000	USD
CY2021Q4	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	37000000	USD
CY2020Q4	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	16600000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	31029000	USD
CY2021	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	0	USD
CY2021	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	0	USD
CY2021	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-7005000	USD
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	24024000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	17779000	USD
CY2020	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	1485000	USD
CY2020	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	712000	USD
CY2020	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	15447000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	31029000	USD
CY2020Q4	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	0	USD
CY2021Q4	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	0	USD
CY2021Q4	ael	Financing Receivable Nonaccrual Number Of Loans FinancingReceivableNonaccrualNumberOfLoans	13	loans
CY2020Q4	ael	Financing Receivable Nonaccrual Number Of Loans FinancingReceivableNonaccrualNumberOfLoans	1	loans
CY2021	us-gaap	Financing Receivable Nonaccrual Interest Income FinancingReceivableNonaccrualInterestIncome	65000	USD
CY2020	us-gaap	Financing Receivable Nonaccrual Interest Income FinancingReceivableNonaccrualInterestIncome	0	USD
CY2019	us-gaap	Financing Receivable Nonaccrual Interest Income FinancingReceivableNonaccrualInterestIncome	0	USD
CY2021	ael	Financing Receivable Modifications Periodof Timeof Delaying Principal And Or Interest FinancingReceivableModificationsPeriodofTimeofDelayingPrincipalAndOrInterest	P3M
CY2021	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	0	loans
CY2020	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	0	loans
CY2021	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	1348735000	USD
CY2020	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	34666000	USD
CY2019	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	906906000	USD
CY2020Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	1300000000	USD
CY2020	us-gaap	Concentration Risk Credit Risk Financial Instrument Maximum Exposure ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure	35100000	USD
CY2021	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	358302000	USD
CY2020	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	1286787000	USD
CY2019	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	-1454042000	USD
CY2021Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	1300000000	USD
CY2021	us-gaap	Concentration Risk Credit Risk Financial Instrument Maximum Exposure ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure	8500000	USD
CY2021	us-gaap	Deferred Policy Acquisition Costs Text Block1 DeferredPolicyAcquisitionCostsTextBlock1	Deferred Policy Acquisition Costs, Deferred Sales Inducements and Liability for Lifetime Income Benefit Riders<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Policy acquisition costs deferred and amortized are as follows:</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,225,199 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,033,649 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,529,855 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Costs deferred during the year:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commissions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">303,192 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">251,428 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">419,166 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Policy issue costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,665 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,725 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,351 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(313,990)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,769)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(280,699)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impact of unlocking</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,662 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(646,785)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">192,982 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of net unrealized gains/losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">299,478 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(414,049)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(831,006)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Write-off related to in-force ceded reinsurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(341,437)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,222,769 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,225,199 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,033,649 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales inducements deferred and amortized are as follows:</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,448,375 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,042,060 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,512,590 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Costs deferred during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">95,160 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">93,610 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">177,941 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(197,799)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10,063)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(193,292)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impact of unlocking</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,107 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(428,101)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104,707 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of net unrealized gains/losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">155,230 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(249,131)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(559,886)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,546,073 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,448,375 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,042,060 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents a rollforward of the liability for lifetime income benefit riders (net of coinsurance ceded):</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,485,123 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,670,750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">790,884 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Benefit expense accrual</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">206,180 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">311,211 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">179,901 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impact of unlocking</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">243,658 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">285,825 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">315,383 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of net unrealized gains/losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(101,848)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">217,337 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">384,582 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reduction related to in-force ceded reinsurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(38,484)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Claim payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,794,629 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,485,123 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,670,750 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We periodically update the key assumptions used in the calculation of amortization of deferred policy acquisition costs and deferred sales inducements retrospectively through an unlocking process when estimates of current or future gross profits/margins (including the impact of realized investment gains and losses) to be realized from a group of products are revised. In addition, we periodically update the assumptions used in determining the liability for lifetime income benefit riders.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We review these assumptions quarterly and as a result of these reviews, we made updates to assumptions in 2021, 2020 and 2019. In addition, we implemented an enhanced actuarial valuation system during 2019, and as a result, our 2019 assumption updates include model refinements resulting from the implementation.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2021, American Equity Life entered into a reinsurance agreement which ceded in-force fixed index annuity product liabilities. As a result, there was a write-off of deferred acquisition costs and a reduction of the liability for lifetime income benefit riders associated with this block of in-force liabilities ceded under the agreement. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Note 9 - Reinsurance and Policy Provisions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for further discussion of this reinsurance agreement. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">2021 Assumption Updates</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The most significant assumption updates made in 2021 were to investment spread assumptions, including the net investment earned rate and crediting rate on policies, lifetime income benefit rider utilization assumptions, mortality assumptions, and lapse rate assumptions as discussed below. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due to the continued low interest rate environment, we updated our assumption for investment spread for American Equity Life to 2.25% in the near term and increasing to 2.50% over an <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFlNDZkMWVhMWIxNzQ0Yzc5M2UyYjNjNWRlMjg5MGFmL3NlYzphZTQ2ZDFlYTFiMTc0NGM3OTNlMmIzYzVkZTI4OTBhZl8xMzYvZnJhZzphMzU0NGEzNThjMTM0MDYxOGIxZTk1MmJjZDAxMGFkZi90ZXh0cmVnaW9uOmEzNTQ0YTM1OGMxMzQwNjE4YjFlOTUyYmNkMDEwYWRmXzIxOTkwMjMyODA4ODk_46b72f30-02ad-472d-af86-3e7976f5f88d">eight</span>-year reversion period and our assumption for crediting/discount rate to 1.55% increasing to 2.10% over an <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFlNDZkMWVhMWIxNzQ0Yzc5M2UyYjNjNWRlMjg5MGFmL3NlYzphZTQ2ZDFlYTFiMTc0NGM3OTNlMmIzYzVkZTI4OTBhZl8xMzYvZnJhZzphMzU0NGEzNThjMTM0MDYxOGIxZTk1MmJjZDAxMGFkZi90ZXh0cmVnaW9uOmEzNTQ0YTM1OGMxMzQwNjE4YjFlOTUyYmNkMDEwYWRmXzIxOTkwMjMyODA5MzQ_950abc1c-d903-4357-8036-ce4e128ee95d">eight</span>-year reversion period. Prior to these assumption updates, our long-term assumption for aggregate investment spread was at 2.60% at then end of an <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFlNDZkMWVhMWIxNzQ0Yzc5M2UyYjNjNWRlMjg5MGFmL3NlYzphZTQ2ZDFlYTFiMTc0NGM3OTNlMmIzYzVkZTI4OTBhZl8xMzYvZnJhZzphMzU0NGEzNThjMTM0MDYxOGIxZTk1MmJjZDAxMGFkZi90ZXh0cmVnaW9uOmEzNTQ0YTM1OGMxMzQwNjE4YjFlOTUyYmNkMDEwYWRmXzIxOTkwMjMyODA5NjQ_e42780f5-6b55-4a91-8c87-f74539f5c269">eight</span>-year reversion period, with a near term crediting/discount rate of 1.60% increasing to 2.10% over an <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFlNDZkMWVhMWIxNzQ0Yzc5M2UyYjNjNWRlMjg5MGFmL3NlYzphZTQ2ZDFlYTFiMTc0NGM3OTNlMmIzYzVkZTI4OTBhZl8xMzYvZnJhZzphMzU0NGEzNThjMTM0MDYxOGIxZTk1MmJjZDAxMGFkZi90ZXh0cmVnaW9uOmEzNTQ0YTM1OGMxMzQwNjE4YjFlOTUyYmNkMDEwYWRmXzIxOTkwMjMyODEwMDU_89798038-d0d0-41cc-b6bc-f76bda5792ac">eight</span>-year reversion period. The assumption change to decrease aggregate investment spread resulted in lower expected future gross profits as compared to previous estimates and a decrease in the balances of deferred policy acquisition costs and deferred sales inducements. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We updated lapse rate and mortality assumptions based on historical experience. For certain annuity products without a lifetime income benefit rider, the lapse rate assumption was increased in more recent cohorts to reflect higher lapses on polices with a market value adjustment ("MVA") feature. For other annuity products with a lifetime income benefit rider, the population was bifurcated based on whether policies had utilized the rider. For those policies which had utilized the rider, the lapse rate assumption was decreased in later durations. The overall mortality assumption was lowered to reflect historical experience. The net impact of the updates to the lapse rate and mortality assumptions resulted in higher expected future gross profits as compared to previous estimates and an increase in the balances of deferred policy acquisition costs and deferred sales inducements. The net impact of the updates to lapse rate and mortality assumptions resulted in an increase in the liability for lifetime income benefit riders due to a greater amount of expected benefit payments in excess of account values. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We updated the lifetime income benefit rider utilization assumption based on historical experience. The ultimate utilization assumption was lowered for policies with a fee rider and certain policies with a no-fee rider. In addition, the utilization assumption was changed to reflect seasonality with higher utilization rates during the first quarter of each year. The net impact of the updates to the utilization assumption resulted in a decrease in the liability for lifetime income benefit riders due to a lower amount of expected benefits payments due to lower expected utilization. The net impact of the updates to the utilization assumption resulted in higher expected future gross profits as compared to previous estimates and an increase in the balances of deferred policy acquisition costs and deferred sales inducements.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">2020 Assumption Updates</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The most significant assumption updates made in 2020 were to investment spread assumptions, including the net investment earned rate and crediting rates on policies, as well as updates to lapse rate and partial withdrawal assumptions.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due to the economic and low interest rate environments, we updated our assumption for aggregate investment spread to 2.40% in the near-term increasing to 2.60% over an <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFlNDZkMWVhMWIxNzQ0Yzc5M2UyYjNjNWRlMjg5MGFmL3NlYzphZTQ2ZDFlYTFiMTc0NGM3OTNlMmIzYzVkZTI4OTBhZl8xMzYvZnJhZzphMzU0NGEzNThjMTM0MDYxOGIxZTk1MmJjZDAxMGFkZi90ZXh0cmVnaW9uOmEzNTQ0YTM1OGMxMzQwNjE4YjFlOTUyYmNkMDEwYWRmXzE1ODY_e42780f5-6b55-4a91-8c87-f74539f5c269">eight</span>-year reversion period and our assumption for crediting/discount rate to 1.60% increasing to 2.10% over an <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFlNDZkMWVhMWIxNzQ0Yzc5M2UyYjNjNWRlMjg5MGFmL3NlYzphZTQ2ZDFlYTFiMTc0NGM3OTNlMmIzYzVkZTI4OTBhZl8xMzYvZnJhZzphMzU0NGEzNThjMTM0MDYxOGIxZTk1MmJjZDAxMGFkZi90ZXh0cmVnaW9uOmEzNTQ0YTM1OGMxMzQwNjE4YjFlOTUyYmNkMDEwYWRmXzE2ODk_89798038-d0d0-41cc-b6bc-f76bda5792ac">eight</span>-year reversion period. Prior to these assumption updates, our long-term assumption for aggregate investment spread was steady at 2.60%, with a near term crediting/discount rate of 1.90% increasing to 2.90% over a 20 year reversion period. The assumption update to decrease aggregate investment spread resulted in lower expected future gross profits as compared to previous estimates and a decrease in the balances of deferred policy acquisition costs and deferred sales inducements. The decrease in the crediting rate, which is used as the discount rate in the calculation of the liability for lifetime income benefit riders, resulted in an increase in the liability for lifetime income benefit riders. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We updated lapse rate and partial withdrawal assumptions based on actual historical experience. For certain annuity products without a lifetime income benefit rider, lapse rate and partial withdrawal assumptions were increased while for certain annuity products with a lifetime income benefit rider, lapse rate and partial withdrawal assumptions were decreased. The net impact of the updates to lapse rate and partial withdrawal assumptions resulted in lower expected future gross profits as compared to previous estimates and a decrease in the balances of deferred policy acquisition costs and deferred sales inducements. The net impact of the updates to lapse rate and partial withdrawal assumptions resulted in an increase in the liability for lifetime income benefit riders due to a greater amount of expected benefit payments in excess of account values.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">2019 Assumption Updates</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The most significant assumption updates made during 2019 were to lapse and utilization assumptions. We had credible lapse and utilization data based upon a comprehensive experience study spanning over 10 years on our products with lifetime income benefit riders and have experienced lapse rates that are lower than previously estimated. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Lower lapse assumptions resulted in an expectation that more policyholders will turn on their lifetime income benefit than previously anticipated which results in a greater amount of benefit payments in excess of account value and the need for a greater liability for lifetime income benefit riders. The decrease in lapse rate assumptions also resulted in policies being in force for a longer period of time and an increase in expected gross profits as compared to previous estimates. The higher level of expected future gross profits resulted in an increase in the balances of deferred policy acquisition costs and deferred sales inducements.</span></div>Our historical experience also indicated that the ultimate utilization of certain lifetime income benefit riders was expected to be less than our prior assumptions and the timing of utilization of lifetime income benefit riders is later than in our prior assumptions. We reduced our ultimate utilization assumptions for fee riders from 75% to 60% and for no-fee riders from 37.5% to 30%, for policies issued in 2014 and prior years. The net effect of the utilization assumption revisions resulted in a decrease in the liability for lifetime income benefit riders and partially offset the increase in the reserve for lifetime income benefit riders from the change in lapse assumptions.In addition, we updated our assumptions regarding future crediting/discount rates. We assumed a 3.80% U.S. Treasury rate with a 20 year mean revision period. Our assumption for aggregate investment spread was 2.60% which translated to an ultimate discount rate of 2.90%. While the aggregate spread of 2.60% did not change from prior estimates, our estimates of the profitability of individual cohorts changed with the use of an aggregate portfolio yield across all cohorts. This assumption update resulted in a change in the allocation of profitability by cohort, which caused a reduction in the deferred policy acquisition costs and deferred sales inducements assets and partially offset the increase in the deferred policy acquisition costs and deferred sales inducements assets from the change in lapse assumptions.
CY2020Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	2225199000	USD
CY2019Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	3033649000	USD
CY2018Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	3529855000	USD
CY2021	ael	Deferred Policy Acquisitions Costs Commissions Deferred DeferredPolicyAcquisitionsCostsCommissionsDeferred	303192000	USD
CY2020	ael	Deferred Policy Acquisitions Costs Commissions Deferred DeferredPolicyAcquisitionsCostsCommissionsDeferred	251428000	USD
CY2020	us-gaap	Deferred Policy Acquisition Costs Amortization Expense Accrued Interest DeferredPolicyAcquisitionCostsAmortizationExpenseAccruedInterest	2769000	USD
CY2019	us-gaap	Deferred Policy Acquisition Costs Amortization Expense Accrued Interest DeferredPolicyAcquisitionCostsAmortizationExpenseAccruedInterest	280699000	USD
CY2021	us-gaap	Deferred Policy Acquisition Cost Amortization Expense Assumption Change DeferredPolicyAcquisitionCostAmortizationExpenseAssumptionChange	-45662000	USD
CY2019	ael	Deferred Policy Acquisitions Costs Commissions Deferred DeferredPolicyAcquisitionsCostsCommissionsDeferred	419166000	USD
CY2021	ael	Deferred Policy Acquisition Costs Policy Issue Costs Deferred DeferredPolicyAcquisitionCostsPolicyIssueCostsDeferred	4665000	USD
CY2020	ael	Deferred Policy Acquisition Costs Policy Issue Costs Deferred DeferredPolicyAcquisitionCostsPolicyIssueCostsDeferred	3725000	USD
CY2019	ael	Deferred Policy Acquisition Costs Policy Issue Costs Deferred DeferredPolicyAcquisitionCostsPolicyIssueCostsDeferred	3351000	USD
CY2021	us-gaap	Deferred Policy Acquisition Costs Amortization Expense Accrued Interest DeferredPolicyAcquisitionCostsAmortizationExpenseAccruedInterest	313990000	USD
CY2020	us-gaap	Deferred Policy Acquisition Cost Amortization Expense Assumption Change DeferredPolicyAcquisitionCostAmortizationExpenseAssumptionChange	646785000	USD
CY2019	us-gaap	Deferred Policy Acquisition Cost Amortization Expense Assumption Change DeferredPolicyAcquisitionCostAmortizationExpenseAssumptionChange	-192982000	USD
CY2021	us-gaap	Deferred Policy Acquisition Cost Unrealized Investment Gain Loss DeferredPolicyAcquisitionCostUnrealizedInvestmentGainLoss	299478000	USD
CY2020	us-gaap	Deferred Policy Acquisition Cost Unrealized Investment Gain Loss DeferredPolicyAcquisitionCostUnrealizedInvestmentGainLoss	-414049000	USD
CY2019	us-gaap	Deferred Policy Acquisition Cost Unrealized Investment Gain Loss DeferredPolicyAcquisitionCostUnrealizedInvestmentGainLoss	-831006000	USD
CY2021	us-gaap	Deferred Policy Acquisition Costs Disposition DeferredPolicyAcquisitionCostsDisposition	341437000	USD
CY2020	us-gaap	Deferred Policy Acquisition Costs Disposition DeferredPolicyAcquisitionCostsDisposition	0	USD
CY2019	us-gaap	Deferred Policy Acquisition Costs Disposition DeferredPolicyAcquisitionCostsDisposition	0	USD
CY2021Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	2222769000	USD
CY2020Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	2225199000	USD
CY2019Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	3033649000	USD
CY2020Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	1448375000	USD
CY2019Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	2042060000	USD
CY2018Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	2512590000	USD
CY2021	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	95160000	USD
CY2020	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	93610000	USD
CY2019	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	177941000	USD
CY2021	us-gaap	Deferred Sales Inducement Cost Amortization Expense Accrued Interest DeferredSalesInducementCostAmortizationExpenseAccruedInterest	197799000	USD
CY2020	us-gaap	Deferred Sales Inducement Cost Amortization Expense Accrued Interest DeferredSalesInducementCostAmortizationExpenseAccruedInterest	10063000	USD
CY2019	us-gaap	Deferred Sales Inducement Cost Amortization Expense Accrued Interest DeferredSalesInducementCostAmortizationExpenseAccruedInterest	193292000	USD
CY2021	us-gaap	Deferred Sales Inducement Cost Amortization Expense Assumption Change DeferredSalesInducementCostAmortizationExpenseAssumptionChange	-45107000	USD
CY2020	us-gaap	Deferred Sales Inducement Cost Amortization Expense Assumption Change DeferredSalesInducementCostAmortizationExpenseAssumptionChange	428101000	USD
CY2019	us-gaap	Deferred Sales Inducement Cost Amortization Expense Assumption Change DeferredSalesInducementCostAmortizationExpenseAssumptionChange	-104707000	USD
CY2021	us-gaap	Deferred Sales Inducement Cost Unrealized Gain Loss On Investment DeferredSalesInducementCostUnrealizedGainLossOnInvestment	155230000	USD
CY2020	us-gaap	Deferred Sales Inducement Cost Unrealized Gain Loss On Investment DeferredSalesInducementCostUnrealizedGainLossOnInvestment	-249131000	USD
CY2019	us-gaap	Deferred Sales Inducement Cost Unrealized Gain Loss On Investment DeferredSalesInducementCostUnrealizedGainLossOnInvestment	-559886000	USD
CY2021Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	1546073000	USD
CY2020Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	1448375000	USD
CY2019Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	2042060000	USD
CY2021Q4	ael	Aggregate Investment Spread Assumption Near Term Rate AggregateInvestmentSpreadAssumptionNearTermRate	0.0225
CY2021Q4	ael	Aggregate Investment Spread Assumption Long Term Rate AggregateInvestmentSpreadAssumptionLongTermRate	0.0250
CY2021Q4	ael	Discount Rate Assumption Near Term Rate DiscountRateAssumptionNearTermRate	0.0155
CY2021Q4	ael	Discount Rate Assumption Long Term Rate DiscountRateAssumptionLongTermRate	0.0210
CY2020Q4	ael	Aggregate Investment Spread Assumption Long Term Rate AggregateInvestmentSpreadAssumptionLongTermRate	0.0260
CY2020Q4	ael	Discount Rate Assumption Near Term Rate DiscountRateAssumptionNearTermRate	0.0160
CY2019Q4	ael	Aggregate Investment Spread Assumption Long Term Rate AggregateInvestmentSpreadAssumptionLongTermRate	0.0260
CY2020Q4	ael	Discount Rate Assumption Long Term Rate DiscountRateAssumptionLongTermRate	0.0210
CY2019Q4	ael	Discount Rate Assumption Near Term Rate DiscountRateAssumptionNearTermRate	0.0190
CY2020Q4	ael	Discount Rate Assumption Near Term Rate DiscountRateAssumptionNearTermRate	0.0160
CY2020Q4	ael	Discount Rate Assumption Long Term Rate DiscountRateAssumptionLongTermRate	0.0210
CY2020Q4	ael	Aggregate Investment Spread Assumption Near Term Rate AggregateInvestmentSpreadAssumptionNearTermRate	0.0240
CY2020Q4	ael	Aggregate Investment Spread Assumption Long Term Rate AggregateInvestmentSpreadAssumptionLongTermRate	0.0260
CY2019Q4	ael	Discount Rate Assumption Long Term Rate DiscountRateAssumptionLongTermRate	0.0290
CY2019	ael	Mean Reversion Period MeanReversionPeriod	P20Y
CY2019	ael	Experience Study Productswith Lifetime Income Benefit Riders Period ExperienceStudyProductswithLifetimeIncomeBenefitRidersPeriod	P10Y
CY2019Q4	ael	Assumptionsfor Future Crediting Rates Us Treasury Rate Assumption AssumptionsforFutureCreditingRatesUSTreasuryRateAssumption	0.0380
CY2019	ael	Mean Reversion Period MeanReversionPeriod	P20Y
CY2019Q4	ael	Aggregate Investment Spread Assumption Long Term Rate AggregateInvestmentSpreadAssumptionLongTermRate	0.0260
CY2019Q4	ael	Discount Rate Assumption Long Term Rate DiscountRateAssumptionLongTermRate	0.0290
CY2019Q4	ael	Aggregate Investment Spread Assumption Long Term Rate AggregateInvestmentSpreadAssumptionLongTermRate	0.0260
CY2021Q4	ael	Third Party Ownership Interest In Companys Common Stock ThirdPartyOwnershipInterestInCompanysCommonStock	0.098
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3430000	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	332000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	12528000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	128423000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	141071000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	56947000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	128755000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	144501000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	69475000	USD
CY2021	us-gaap	Income Tax Effects Allocated Directly To Equity Cumulative Effect Of Change In Accounting Principle IncomeTaxEffectsAllocatedDirectlyToEquityCumulativeEffectOfChangeInAccountingPrinciple	0	USD
CY2020	us-gaap	Income Tax Effects Allocated Directly To Equity Cumulative Effect Of Change In Accounting Principle IncomeTaxEffectsAllocatedDirectlyToEquityCumulativeEffectOfChangeInAccountingPrinciple	-2543000	USD
CY2019	us-gaap	Income Tax Effects Allocated Directly To Equity Cumulative Effect Of Change In Accounting Principle IncomeTaxEffectsAllocatedDirectlyToEquityCumulativeEffectOfChangeInAccountingPrinciple	0	USD
CY2021	us-gaap	Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent	-90284000	USD
CY2020	us-gaap	Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent	225746000	USD
CY2019	us-gaap	Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent	372472000	USD
CY2021	us-gaap	Income Tax Expense Benefit Intraperiod Tax Allocation IncomeTaxExpenseBenefitIntraperiodTaxAllocation	38471000	USD
CY2020	us-gaap	Income Tax Expense Benefit Intraperiod Tax Allocation IncomeTaxExpenseBenefitIntraperiodTaxAllocation	367704000	USD
CY2019	us-gaap	Income Tax Expense Benefit Intraperiod Tax Allocation IncomeTaxExpenseBenefitIntraperiodTaxAllocation	441947000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	602747000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	815961000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	315565000	USD
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	126577000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	171352000	USD
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	66269000	USD
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	5239000	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	5749000	USD
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	5111000	USD
CY2021	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	4715000	USD
CY2020	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	4602000	USD
CY2019	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	4385000	USD
CY2021	ael	Effective Income Tax Rate Reconciliation Tax Rate Differential On Net Operating Loss Carryback Related To Cares Act EffectiveIncomeTaxRateReconciliationTaxRateDifferentialOnNetOperatingLossCarrybackRelatedToCARESAct	0	USD
CY2020	ael	Effective Income Tax Rate Reconciliation Tax Rate Differential On Net Operating Loss Carryback Related To Cares Act EffectiveIncomeTaxRateReconciliationTaxRateDifferentialOnNetOperatingLossCarrybackRelatedToCARESAct	30041000	USD
CY2019	ael	Effective Income Tax Rate Reconciliation Tax Rate Differential On Net Operating Loss Carryback Related To Cares Act EffectiveIncomeTaxRateReconciliationTaxRateDifferentialOnNetOperatingLossCarrybackRelatedToCARESAct	0	USD
CY2021	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	1654000	USD
CY2020	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	2043000	USD
CY2019	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	2480000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	128755000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	144501000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	69475000	USD
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.214
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.177
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.220
CY2020	ael	Effective Statutory Tax Rate Used For Net Operating Loss Carryback Percent EffectiveStatutoryTaxRateUsedForNetOperatingLossCarrybackPercent	0.35
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities	1373485000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities	1586000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses	15275000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses	28519000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	3332000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	3789000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther	3434000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther	2161000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	5171000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2189000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	87314000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1140000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3569000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1489151000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1626227000	USD
CY2021Q4	ael	Deferred Tax Liabilities Deferred Policy Acquisition Costs And Deferred Sales Inducements DeferredTaxLiabilitiesDeferredPolicyAcquisitionCostsAndDeferredSalesInducements	1170859000	USD
CY2020Q4	ael	Deferred Tax Liabilities Deferred Policy Acquisition Costs And Deferred Sales Inducements DeferredTaxLiabilitiesDeferredPolicyAcquisitionCostsAndDeferredSalesInducements	1268790000	USD
CY2021Q4	ael	Deferred Tax Liabilities Unrealized Gain On Available For Sale Securities Gross DeferredTaxLiabilitiesUnrealizedGainOnAvailableForSaleSecuritiesGross	489290000	USD
CY2020Q4	ael	Deferred Tax Liabilities Unrealized Gain On Available For Sale Securities Gross DeferredTaxLiabilitiesUnrealizedGainOnAvailableForSaleSecuritiesGross	579766000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Derivatives DeferredTaxLiabilitiesDerivatives	107717000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Derivatives DeferredTaxLiabilitiesDerivatives	119444000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Reserves And Accruals DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals	98616000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Reserves And Accruals DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals	123270000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	56285000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	28719000	USD
CY2021Q4	ael	Deferred Tax Liabilities Amounts Due Reinsurer DeferredTaxLiabilitiesAmountsDueReinsurer	103234000	USD
CY2021	us-gaap	Securities Sold Under Agreements To Repurchase Average Amount Outstanding SecuritiesSoldUnderAgreementsToRepurchaseAverageAmountOutstanding	0	USD
CY2020Q4	ael	Deferred Tax Liabilities Amounts Due Reinsurer DeferredTaxLiabilitiesAmountsDueReinsurer	5636000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	5122000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	4602000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2031123000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2130227000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	541972000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	504000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	USD
CY2021	ael	Income Tax Examination Period Subject To Examination IncomeTaxExaminationPeriodSubjectToExamination	P3Y
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	87300000	USD
CY2021Q4	us-gaap	Notes Payable NotesPayable	496250000	USD
CY2020Q4	us-gaap	Notes Payable NotesPayable	495668000	USD
CY2020	us-gaap	Securities Sold Under Agreements To Repurchase Average Amount Outstanding SecuritiesSoldUnderAgreementsToRepurchaseAverageAmountOutstanding	14300000	USD
CY2019	us-gaap	Securities Sold Under Agreements To Repurchase Average Amount Outstanding SecuritiesSoldUnderAgreementsToRepurchaseAverageAmountOutstanding	33000000	USD
CY2020	ael	Securities Sold Under Agreements To Repurchase Maximum Amount Borrowed SecuritiesSoldUnderAgreementsToRepurchaseMaximumAmountBorrowed	186400000	USD
CY2019	ael	Securities Sold Under Agreements To Repurchase Maximum Amount Borrowed SecuritiesSoldUnderAgreementsToRepurchaseMaximumAmountBorrowed	243600000	USD
CY2020	srt	Securities Sold Under Agreements To Repurchase Average Rate Paid SecuritiesSoldUnderAgreementsToRepurchaseAverageRatePaid	0.0173
CY2019	srt	Securities Sold Under Agreements To Repurchase Average Rate Paid SecuritiesSoldUnderAgreementsToRepurchaseAverageRatePaid	0.0299
CY2021	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	19500	USD
CY2020	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	19500	USD
CY2019	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	19000	USD
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2700000	USD
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2400000	USD
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1800000	USD
CY2021	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	3377000	USD
CY2020	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	2908000	USD
CY2019	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	2547000	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	27525000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11819000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10028000	USD
CY2021	ael	Employee Stock Ownership Plan Requisite Service Period EmployeeStockOwnershipPlanRequisiteServicePeriod	P6M
CY2021	ael	Employee Stock Ownership Plan Vesting Percentage EmployeeStockOwnershipPlanVestingPercentage	1
CY2021	ael	Employee Stock Ownership Plan Esop Vesting Period EmployeeStockOwnershipPlanESOPVestingPeriod	P2Y
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1221865	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	17.41
CY2018Q4	ael	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Total Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingTotalExercisePrice	21273000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2019	ael	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Total Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodTotalExercisePrice	0	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	22600	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	18.14
CY2019	ael	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Total Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodTotalExercisePrice	410000	USD
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	370352	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	11.76
CY2019	ael	Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisedin Period Total Exercise Price SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisedinPeriodTotalExercisePrice	4357000	USD
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	828913	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	19.91
CY2019Q4	ael	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Total Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingTotalExercisePrice	16506000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	815767	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	26.70
CY2020	ael	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Total Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodTotalExercisePrice	21778000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	31200	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	21.50
CY2020	ael	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Total Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodTotalExercisePrice	670000	USD
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	355563	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	16.98
CY2020	ael	Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisedin Period Total Exercise Price SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisedinPeriodTotalExercisePrice	6038000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1257917	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	25.10
CY2020Q4	ael	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Total Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingTotalExercisePrice	31576000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1246605	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	29.15
CY2021	ael	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Total Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodTotalExercisePrice	36336000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	146803	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	25.44
CY2021	ael	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Total Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodTotalExercisePrice	3735000	USD
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	295000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	22.88
CY2021	ael	Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisedin Period Total Exercise Price SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisedinPeriodTotalExercisePrice	6749000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2062719	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	27.84
CY2021Q4	ael	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Total Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingTotalExercisePrice	57428000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	22900000	USD
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1200000	USD
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6700000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6000000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4400000	USD
CY2021	us-gaap	Statutory Accounting Practices Statutory Net Income Amount StatutoryAccountingPracticesStatutoryNetIncomeAmount	-863818000	USD
CY2020	us-gaap	Statutory Accounting Practices Statutory Net Income Amount StatutoryAccountingPracticesStatutoryNetIncomeAmount	-34467000	USD
CY2019	us-gaap	Statutory Accounting Practices Statutory Net Income Amount StatutoryAccountingPracticesStatutoryNetIncomeAmount	143309000	USD
CY2021Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	4078532000	USD
CY2020Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	3728732000	USD
CY2021	us-gaap	Statutory Accounting Practices Permitted Practice Amount StatutoryAccountingPracticesPermittedPracticeAmount	210200000	USD
CY2020	us-gaap	Statutory Accounting Practices Permitted Practice Amount StatutoryAccountingPracticesPermittedPracticeAmount	366300000	USD
CY2021Q4	ael	Statutory Accounting Practices Statutory Capital And Surplus Total Ad Justed Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusTotalAdJustedBalance	4437574000	USD
CY2020Q4	ael	Statutory Accounting Practices Statutory Capital And Surplus Total Ad Justed Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusTotalAdJustedBalance	3978901000	USD
CY2021Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Required StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired	1108796000	USD
CY2020Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Required StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired	1069434000	USD
CY2021Q4	us-gaap	Capital To Risk Weighted Assets CapitalToRiskWeightedAssets	4
CY2020Q4	us-gaap	Capital To Risk Weighted Assets CapitalToRiskWeightedAssets	3.72
CY2021	ael	Dividend Restriction Percentage Policyholders Surplus DividendRestrictionPercentagePolicyholdersSurplus	0.10
CY2021Q4	us-gaap	Statutory Accounting Practices Statutory Amount Available For Dividend Payments Without Regulatory Approval StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval	407900000	USD
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	3800000	USD
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	4200000	USD
CY2019	us-gaap	Operating Lease Expense OperatingLeaseExpense	3300000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	12600000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2509000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2296000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2268000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2154000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1780000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1567000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	430317000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	637945000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	246090000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	93860378	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	92055035	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	91139453	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	94491159	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	92392496	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	91782242	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.58
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	6.93
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.70
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.55
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.90
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.68
CY2020Q4	ael	Third Party Equity Investment Number Of Stages ThirdPartyEquityInvestmentNumberOfStages	2	numberOfStages
CY2020Q4	ael	Number Of Board Of Directors Seats Third Party Received Following Initial Equity Investment NumberOfBoardOfDirectorsSeatsThirdPartyReceivedFollowingInitialEquityInvestment	1	boardOfDirectorsSeats
CY2020Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	500000000	USD
CY2021Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	500000000	USD
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	9100000	shares
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	29.04
CY2021Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	736000000	USD
CY2021Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	9936715	shares
CY2021Q4	us-gaap	Treasury Stock Carrying Basis TreasuryStockCarryingBasis	260600000	USD
CY2020Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	6516525	shares
CY2020Q4	us-gaap	Treasury Stock Carrying Basis TreasuryStockCarryingBasis	151600000	USD
CY2021Q4	us-gaap	Summary Of Investments Other Than Investments In Related Parties Cost SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCost	55189841000	USD
CY2021Q4	us-gaap	Summary Of Investments Other Than Investments In Related Parties Carrying Amount SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount	60376504000	USD
CY2021Q4	us-gaap	Supplementary Insurance Information Deferred Policy Acquisition Costs SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts	2222769000	USD
CY2021Q4	us-gaap	Supplementary Insurance Information Liability For Future Policy Benefits Losses Claims And Loss Expense Reserves SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves	65477778000	USD
CY2021Q4	us-gaap	Supplementary Insurance Information Unearned Premiums SupplementaryInsuranceInformationUnearnedPremiums	0	USD
CY2021Q4	us-gaap	Supplementary Insurance Information Other Policy Claims And Benefits Payable SupplementaryInsuranceInformationOtherPolicyClaimsAndBenefitsPayable	226844000	USD
CY2020Q4	us-gaap	Supplementary Insurance Information Deferred Policy Acquisition Costs SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts	2225199000	USD
CY2020Q4	us-gaap	Supplementary Insurance Information Liability For Future Policy Benefits Losses Claims And Loss Expense Reserves SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves	62352882000	USD
CY2020Q4	us-gaap	Supplementary Insurance Information Unearned Premiums SupplementaryInsuranceInformationUnearnedPremiums	0	USD
CY2020Q4	us-gaap	Supplementary Insurance Information Other Policy Claims And Benefits Payable SupplementaryInsuranceInformationOtherPolicyClaimsAndBenefitsPayable	240904000	USD
CY2019Q4	us-gaap	Supplementary Insurance Information Deferred Policy Acquisition Costs SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts	3033649000	USD
CY2019Q4	us-gaap	Supplementary Insurance Information Liability For Future Policy Benefits Losses Claims And Loss Expense Reserves SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves	62261244000	USD
CY2019Q4	us-gaap	Supplementary Insurance Information Unearned Premiums SupplementaryInsuranceInformationUnearnedPremiums	0	USD
CY2019Q4	us-gaap	Supplementary Insurance Information Other Policy Claims And Benefits Payable SupplementaryInsuranceInformationOtherPolicyClaimsAndBenefitsPayable	256105000	USD
CY2021	us-gaap	Supplementary Insurance Information Premium Revenue SupplementaryInsuranceInformationPremiumRevenue	300833000	USD
CY2021	us-gaap	Supplementary Insurance Information Net Investment Income SupplementaryInsuranceInformationNetInvestmentIncome	2037475000	USD
CY2021	us-gaap	Supplementary Insurance Information Benefits Claims Losses And Settlement Expense SupplementaryInsuranceInformationBenefitsClaimsLossesAndSettlementExpense	2543779000	USD
CY2021	us-gaap	Supplementary Insurance Information Amortization Of Deferred Policy Acquisition Costs SupplementaryInsuranceInformationAmortizationOfDeferredPolicyAcquisitionCosts	268328000	USD
CY2021	us-gaap	Supplementary Insurance Information Other Operating Expense SupplementaryInsuranceInformationOtherOperatingExpense	274617000	USD
CY2020	us-gaap	Supplementary Insurance Information Premium Revenue SupplementaryInsuranceInformationPremiumRevenue	290609000	USD
CY2020	us-gaap	Supplementary Insurance Information Net Investment Income SupplementaryInsuranceInformationNetInvestmentIncome	2182078000	USD
CY2020	us-gaap	Supplementary Insurance Information Benefits Claims Losses And Settlement Expense SupplementaryInsuranceInformationBenefitsClaimsLossesAndSettlementExpense	744389000	USD
CY2020	us-gaap	Supplementary Insurance Information Amortization Of Deferred Policy Acquisition Costs SupplementaryInsuranceInformationAmortizationOfDeferredPolicyAcquisitionCosts	649554000	USD
CY2020	us-gaap	Supplementary Insurance Information Other Operating Expense SupplementaryInsuranceInformationOtherOperatingExpense	214745000	USD
CY2019	us-gaap	Supplementary Insurance Information Premium Revenue SupplementaryInsuranceInformationPremiumRevenue	263569000	USD
CY2019	us-gaap	Supplementary Insurance Information Net Investment Income SupplementaryInsuranceInformationNetInvestmentIncome	2307635000	USD
CY2019	us-gaap	Supplementary Insurance Information Benefits Claims Losses And Settlement Expense SupplementaryInsuranceInformationBenefitsClaimsLossesAndSettlementExpense	2865621000	USD
CY2019	us-gaap	Supplementary Insurance Information Amortization Of Deferred Policy Acquisition Costs SupplementaryInsuranceInformationAmortizationOfDeferredPolicyAcquisitionCosts	87717000	USD
CY2019	us-gaap	Supplementary Insurance Information Other Operating Expense SupplementaryInsuranceInformationOtherOperatingExpense	195442000	USD
CY2021Q4	srt	Life Insurance In Force Gross LifeInsuranceInForceGross	48943000	USD
CY2021Q4	srt	Life Insurance In Force Ceded LifeInsuranceInForceCeded	5131000	USD
CY2021Q4	srt	Life Insurance In Force Assumed LifeInsuranceInForceAssumed	46119000	USD
CY2021Q4	srt	Life Insurance In Force Net LifeInsuranceInForceNet	89931000	USD
CY2021Q4	srt	Life Insurance In Force Percentage Assumed To Net LifeInsuranceInForcePercentageAssumedToNet	0.5128
CY2020Q4	srt	Life Insurance In Force Gross LifeInsuranceInForceGross	52234000	USD
CY2020Q4	srt	Life Insurance In Force Ceded LifeInsuranceInForceCeded	5925000	USD
CY2020Q4	srt	Life Insurance In Force Assumed LifeInsuranceInForceAssumed	49577000	USD
CY2020Q4	srt	Life Insurance In Force Net LifeInsuranceInForceNet	95886000	USD
CY2020Q4	srt	Life Insurance In Force Percentage Assumed To Net LifeInsuranceInForcePercentageAssumedToNet	0.5170
CY2019Q4	srt	Life Insurance In Force Gross LifeInsuranceInForceGross	56451000	USD
CY2019Q4	srt	Life Insurance In Force Ceded LifeInsuranceInForceCeded	6722000	USD
CY2019Q4	srt	Life Insurance In Force Assumed LifeInsuranceInForceAssumed	52653000	USD
CY2019Q4	srt	Life Insurance In Force Net LifeInsuranceInForceNet	102382000	USD
CY2019Q4	srt	Life Insurance In Force Percentage Assumed To Net LifeInsuranceInForcePercentageAssumedToNet	0.5143

Files In Submission

Name	View Source	Status
0001039828-22-000022-index-headers.html	Edgar Link	pending
0001039828-22-000022-index.html	Edgar Link	pending
0001039828-22-000022.txt	Edgar Link	pending
0001039828-22-000022-xbrl.zip	Edgar Link	pending
a2021-12x31ex1033.htm	Edgar Link	pending
a2021-12x31ex212.htm	Edgar Link	pending
a2021-12x31ex231.htm	Edgar Link	pending
a2021-12x31ex232.htm	Edgar Link	pending
a2021-12x31ex311.htm	Edgar Link	pending
a2021-12x31ex312.htm	Edgar Link	pending
a2021-12x31ex321.htm	Edgar Link	pending
a2021-12x31ex322.htm	Edgar Link	pending
a2021-12x31ex411.htm	Edgar Link	pending
ael-20211231.htm	Edgar Link	pending
ael-20211231.xsd	Edgar Link	pending
ael-20211231_cal.xml	Edgar Link	unprocessable
ael-20211231_def.xml	Edgar Link	unprocessable
ael-20211231_g1.jpg	Edgar Link	pending
ael-20211231_htm.xml	Edgar Link	completed
ael-20211231_lab.xml	Edgar Link	unprocessable
ael-20211231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image_0.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ANG-PA
American National Group Inc. Stock $ang-pa

2021 Form 10-K Financial Statement

#000103982822000022 Filed on March 01, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ANG-PA American National Group Inc. Stock $ang-pa

2021 Form 10-K Financial Statement

#000103982822000022 Filed on March 01, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ANG-PA
American National Group Inc. Stock $ang-pa